Published in Br J Pharmacol on July 01, 1995
Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol (1996) 1.72
Purinergic signalling in the gastrointestinal tract and related organs in health and disease. Purinergic Signal (2013) 0.95
Different receptors mediating the inhibitory action of exogenous ATP and endogenously released purines on guinea-pig intestinal peristalsis. Br J Pharmacol (1999) 0.94
Characterization and tissue location of the neural adenosine receptor in the rat ileum. Br J Pharmacol (1999) 0.90
Purinergic mechanisms in the control of gastrointestinal motility. Purinergic Signal (2007) 0.88
Modulatory effect of adenosine receptors on the ascending and descending neural reflex responses of rat ileum. BMC Neurosci (2002) 0.85
The pharmacological estimation of adenosine and histamine in blood. J Physiol (1935) 34.66
The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol (1929) 23.79
Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol (1970) 8.20
Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther (1989) 4.18
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol (1986) 4.15
Overview. Purinergic mechanisms. Ann N Y Acad Sci (1990) 2.66
P1- and P2-purinoceptor subtypes--an update. Arch Int Pharmacodyn Ther (1990) 2.22
Adenosine receptor subtypes. Trends Pharmacol Sci (1993) 1.99
A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mol Pharmacol (1994) 1.87
Distension-evoked ascending and descending reflexes in the circular muscle of guinea-pig ileum: an intracellular study. J Auton Nerv Syst (1990) 1.56
Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endocrinol (1992) 1.55
PD 115,199: an antagonist ligand for adenosine A2 receptors. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.48
2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.47
Evidence for an A1-adenosine receptor in the guinea-pig atrium. Br J Pharmacol (1983) 1.44
Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors. FEBS Lett (1986) 1.42
Characterization of P1-purinoceptors on rat duodenum and urinary bladder. Br J Pharmacol (1992) 1.35
Apparent affinity of 1,3-dipropyl-8-cyclopentylxanthine for adenosine A1 and A2 receptors in isolated tissues from guinea-pigs. Br J Pharmacol (1989) 1.35
Characterization of the P1-purinoceptors mediating contraction of the rat colon muscularis mucosae. Br J Pharmacol (1992) 1.34
PD 116,948, a highly selective A1 adenosine receptor antagonist. Life Sci (1987) 1.23
Effects of purines on the longitudinal muscle of the rat colon. Br J Pharmacol (1992) 1.17
Effects of purine compounds on cholinergic nerves. Specificity of adenosine and related compounds on acetylcholine release in electircally stimulated guinea pig ileum. Eur J Pharmacol (1978) 1.05
Electrical activity of longitudinal and circular muscle during peristalsis. Am J Physiol (1983) 1.04
Heterogeneous vasomotor responses of anatomically distinct feline cerebral arteries. Br J Pharmacol (1988) 0.97
The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations. Br J Pharmacol (1994) 0.96
Quantitative studies of the release of purine compounds following stimulation of non-adrenergic inhibitory nerves in the stomach. Biochem Pharmacol (1971) 0.93
Novel form of drug-dependence--on adenosine in guinea pig ileum. Nature (1983) 0.88
Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum. Gen Pharmacol (1988) 0.86
Unexpected reversal effects of naloxone on the guinea pig ileum. Life Sci (1976) 0.83
Effect of adenosine analogues on the expression of opiate withdrawal in rats. Pharmacol Biochem Behav (1992) 0.83
The adenosine agonist NECA inhibits intestinal secretion and peristalsis. J Pharm Pharmacol (1994) 0.81
Functional characterization of the adenosine receptor mediating inhibition of intestinal secretion. Br J Pharmacol (1995) 0.79
Regional distribution of an opioid mechanism in the guinea-pig isolated intestine. J Pharm Pharmacol (1981) 0.78
The effect of metoclopramide on inhibition induced by purine nucleotides, noradrenaline, and theophylline ethylenediamine on intestinal muscle and on peristalsis in vitro. Can J Physiol Pharmacol (1975) 0.77
Relative potencies of sympathetic amines in human smooth muscle. Br J Pharmacol (1969) 1.98
Action of fenfluramine on isolated human smooth muscle. Lancet (1969) 1.94
Insights into opioid action in the intestinal tract. Pharmacol Ther (1996) 1.61
A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum. Br J Pharmacol (1995) 1.19
Antiinflammatory screening of the medicinal plant Gynura procumbens. Plant Foods Hum Nutr (2002) 1.07
Relative affinities of some alpha-adrenoceptor blocking drugs in isolated human smooth muscle. Br J Pharmacol (1970) 1.04
Opioid action of the intestine: the importance of the intestinal mucosa. Life Sci (1987) 0.99
Inhibition by morphine of prostaglandin-stimulated fluid secretion in rat jejunum. Br J Pharmacol (1978) 0.97
Characterisation of a postjunctional 5-ht7-like and a prejunctional 5-HT3 receptor mediating contraction of rat isolated jejunum. Eur J Pharmacol (1996) 0.95
Stimulatory effects of 5-hydroxytryptamine on fluid secretion and transmural potential difference in rat small intestine are mediated by different receptor subtypes. J Pharm Pharmacol (1990) 0.95
[3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum. Br J Pharmacol (1999) 0.91
The influence of prostaglandins on noradrenaline-induced vasoconstriction isolated perfused mesenteric blood vessels of the rat. Br J Pharmacol (1978) 0.91
Inhibition of glucose absorption by prostaglandins E 1 , E 2 and F 2 . J Pharm Pharmacol (1972) 0.89
Competitive antagonism of alpha 1-adrenoceptor mediated pressor responses in the rat mesenteric artery. J Pharm Pharmacol (1984) 0.89
5-HT4 receptor antagonist affinities of SB207710, SB205008, and SB203186 in the human colon, rat oesophagus, and guinea-pig ileum peristaltic reflex. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.89
The effect of clonidine on human isolated smooth muscle. Eur J Pharmacol (1972) 0.87
The effect of isoprenaline on adrenoceptors in human saphenous vein. Br J Pharmacol (1970) 0.87
The effect of acute and chronic administration of morphine and morphine withdrawal on intestinal transit time in the rat. J Pharm Pharmacol (1988) 0.86
Characterisation of pre- and post-synaptic alpha-adrenoceptors in modulation of the rat ileum longitudinal and circular muscle activities. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.86
Expression patterns of 5-HT7 receptor isoforms in the rat digestive tract. Life Sci (2001) 0.86
Effect of adenosine analogues on the expression of opiate withdrawal in rats. Pharmacol Biochem Behav (1992) 0.83
Stimulation of cyclic AMP formation in the circular smooth muscle of human colon by activation of 5-HT4-like receptors. Br J Pharmacol (1996) 0.83
Stimulation of sodium and water secretion without inhibition of glucose absorption in the rat jejunum by vasoactive intestinal peptide (VIP). Clin Exp Pharmacol Physiol (1977) 0.82
Distribution of serotonin receptors and interacting proteins in the human sigmoid colon. Neurogastroenterol Motil (2008) 0.82
Role of alpha 2-adrenoceptors in the regulation of intestinal water transport. Br J Pharmacol (1997) 0.82
Relative potencies of some false transmitters on isolated human smooth muscle. Br J Pharmacol (1970) 0.82
The inhibitory response of the rabbit anococcygeus muscle. Clin Exp Pharmacol Physiol (1976) 0.81
Influences of gender and region on responses to 5-HT in the rat small intestine. Pharmacology (2004) 0.81
Comparison of opioid receptor distributions in the rat ileum. Life Sci (2005) 0.80
Alteration in the level of endogenous hypothalamic prostaglandins induced by delta 9-tetrahydrocannabinol in the rat. Br J Pharmacol (1982) 0.80
Opiate receptor-mediated inhibition of rat jejunal fluid secretion. Life Sci (1980) 0.80
Prostaglandin action, release and inactivation by rat isolated perfused mesenteric blood vessels. Br J Pharmacol (1980) 0.80
Functional characterization of the adenosine receptor mediating inhibition of intestinal secretion. Br J Pharmacol (1995) 0.79
Further investigation into the signal transduction mechanism of the 5-HT4-like receptor in the circular smooth muscle of human colon. Br J Pharmacol (1996) 0.78
Tachykinin receptors in the guinea-pig isolated oesophagus: a complex system. Br J Pharmacol (1997) 0.78
Choice of anesthetic for intestinal absorption and secretion experiments using rats. J Pharmacol Methods (1985) 0.78
Lack of evidence for histamine H3 receptor function in rat ileum and human colon. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.78
The effect of BW 755C and nordihydroguaiaretic acid in the rat isolated perfused mesenteric vasculature. Prostaglandins Leukot Med (1986) 0.77
Demonstration of 5-HT(3) receptor function and expression in the mouse bladder. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.77
Difenoxin and loperamide: studies on possible mechanisms of intestinal antisecretory action. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.77
Inhibition of intestinal secretion without reduction of cyclic AMP levels. Eur J Pharmacol (1980) 0.77
Effect of the novel 5-HT4 receptor agonist DAU 6236 in human colon. Med J Aust (1994) 0.77
Evidence for tryptaminergic and noradrenergic involvement in the antisecretory action of morphine in the rat jejunum. J Pharm Pharmacol (1987) 0.77
Evidence for functional delta-opiate receptors in the rat intestine. J Pharm Pharmacol (1994) 0.77
Characterisation of a 5-HT(7) binding site in mouse ileum. Eur J Pharmacol (2000) 0.76
Changes in sensitivity of 5-HT receptor mediated functional responses in the rat oesophagus, fundus and jejunum following chronic infusion with 5-hydroxytryptamine. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.76
Glucose absorption from the rat jejunum during acute exposure to metformin and phenformin. J Pharm Pharmacol (1974) 0.75
Characterization of the opiate receptor population mediating inhibition of VIP-induced secretion from the small intestine of the rat. Br J Pharmacol (1983) 0.75
Involvement of alpha-2 adrenoceptors in the effects of moxonidine on intestinal motility and fluid transport. J Pharmacol Exp Ther (1997) 0.75
Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors. Br J Pharmacol (2000) 0.75
Evidence for functional alpha 2D-adrenoceptors in the rat intestine. Br J Pharmacol (1996) 0.75
Evidence against the involvement of prostaglandins in the vasoconstrictor action of calcium ion in rat mesenteric blood vessels. Br J Pharmacol (1981) 0.75
Investigation into the effect of 5-hydroxytryptamine on fluid transport in the rat small intestine. Gen Pharmacol (1998) 0.75
The use of tripeptides for lead discovery of 5-HT4 receptor ligands. Protein Pept Lett (2009) 0.75
The possible control of intestinal absorption by substances occurring in the gut wall. Guys Hosp Rep (1974) 0.75
Tetrodotoxin inhibits directly acting stimulants of intestinal fluid secretion. J Pharm Pharmacol (1986) 0.75
The activity of non-steroidal anti-inflammatory drugs in the rat mesenteric vasculature. J Pharm Pharmacol (1986) 0.75
The effects of taloximine and aminophylline on isolated human smooth muscle. Arch Int Pharmacodyn Ther (1969) 0.75
Influence of the thromboxane-mimetic U-46619 and the prostacyclin metabolite 6-keto prostaglandin E1 on vasoconstriction induced by noradrenaline and 5-HT in rat mesenteric vasculature. Prostaglandins Leukot Essent Fatty Acids (1988) 0.75
Synthesis and preliminary screening of novel tryptamines as 5-HT4 receptor ligands. Curr Med Chem (2010) 0.75
Evidence implicating a prostaglandin as the mediator of intestinal fluid secretion induced by pithing: inhibition by indomethacin, morphine and pentobarbitone. J Pharm Pharmacol (1982) 0.75
Tachykinins play a minor role in mediating the third phase of the contractile response to vagal nerve stimulation of the guinea-pig oesophagus. Neuropeptides (2000) 0.75
Studies to determine whether there is tolerance or cross-tolerance to the antisecretory effect of morphine and clonidine in the rat intestine. J Pharm Pharmacol (1991) 0.75
Evidence of H3 receptor inhibition by iodoaminopotentidine in the guinea pig ileum. Life Sci (1998) 0.75
Evidence for peptidase activity in the rat intestine. J Auton Pharmacol (1995) 0.75
Inhibition by morphine of dibutyryl cyclic AMP-induced fluid secretion from the rat jejunum. J Pharm Pharmacol (1983) 0.75
Effect of aminophylline, butalamine and imolamine on human isolated smooth muscle. J Pharm Pharmacol (1969) 0.75
Effect of levonorgestrel and ethinyloestradiol on vasoconstriction in rat isolated vasculature. J Pharm Pharmacol (1988) 0.75
Effect of delta 9-tetrahydrocannabinol on prostaglandin concentrations and fluid absorption rates in the rat small intestine. J Pharm Pharmacol (1983) 0.75
Vagal nerve stimulation of the guinea-pig oesophagus. Acta Physiol Scand (1995) 0.75
Opiate agonist and antagonist action on guinea-pig isolated ileum. Gen Pharmacol (1994) 0.75
Fenfluramine and phenmetrazine. Lancet (1969) 0.75
Do antidiarrhoeal opiates accumulate in the rat intestinal lumen? J Pharm Pharmacol (1993) 0.75
Studies investigating the possible involvement of adenosine in the antisecretory action of morphine. Gen Pharmacol (1997) 0.75